MSMark D. Shen

Mark D. Shen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark D. Shen has a total of 367 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SORDINO: silent, sensitive, specific and artifact-resistant fMRI in awake, behaving mice

    by Martin J. MacKinnon, Sheng Song, Tzu-Hao Harry Chao, Li-Ming Hsu, Scott T. Albert, Yuncong Ma, Tatiana A. Shnitko, Tzu-Wen Winnie Wang, Randy J. Nonneman, Corey D. Freeman, et al.

    Blood-oxygenation-level-dependent (BOLD) functional magnetic resonance imaging (fMRI) has advanced brain mapping across species. This widely used technique, however, faces challenges such as acoustic noise, electromagnetic interference, motion artifacts, magnetic-field inhomogeneity and limitations in sensitivity and specificity. Here we introduce Steady-state On-the-Ramp Detection of INduction-decay with Oversampling (SORDINO), an improved zero echo time (ZTE)-based fMRI technique that maintains ultra-low slew rate and acquires data exclusively during gradient direction changes. At 9.4 T, SORDINO outperforms conventional gradient-recalled-echo-based echo-planar imaging and ZTE in metrics crucial for fMRI while being silent, sensitive, specific and resistant to motion and susceptibility artifacts. We showcase SORDINO’s superior compatibility with multimodal experiments and reveal T1-based contrast mechanisms distinct from BOLD that are expected to generalize across ZTE-based fMRI techniques. We further demonstrate SORDINO brain-wide activity and functional connectivity mapping in awake, behaving mice, overcoming stress-related, motion-related and sensitivity-related limitations that remain common barriers in current animal fMRI studies.


  • Open Access

    Assessment of adaptive functioning in Angelman syndrome using the Vineland Adaptive Behavior Scales, Third Edition

    by Sarah Nelson Potter, Julia Zhang, Batsheva Friedman, Julia Gable, Nadia Ali, Rene L. Barbieri-Welge, Ayala Ben-Tall, Kelly E. Caravella, Margaret DeRamus, Dea Garic, et al.

    Purpose: This study examined longitudinal trajectories of adaptive functioning in 331 individuals with Angelman syndrome (AS) using the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) and examined differences by molecular subtype. Methods: A total of 331 individuals (156 females, 47%) with genetically confirmed AS (ages 6 months to 52 years) were assessed between 2018 and 2025, including 207 with a deletion subtype, 63 with uniparental disomy or imprinting defect, and 61 with a UBE3A point mutation. Growth scale values were analyzed using linear mixed-effects models with log 2 -transformed age. Results: Individuals with deletion subtypes demonstrated significantly lower adaptive functioning across domains compared to those with non-deletion subtypes. Adaptive skills across all Vineland-3 subdomains increased nonlinearly with age, showing faster growth early in life that slowed over time, with largely parallel trajectories across subtypes. Conclusion: Individuals with AS demonstrate slow but steady growth in adaptive functioning that continues into adulthood, with progress varying by molecular subtype. These findings provide updated natural history benchmarks and demonstrate the utility of the Vineland-3 for clinical trials.

  • Open Access

    Variation in infant subcortical brain development from 6 to 12 months in Down syndrome

    by Dea Garic, Mengwei Ren, Zoë Hawks, Yoonmi Hong, Carolyn Lasch, Rebecca Grzadzinski, Sun Hyung Kim, Omar Azrak, Jed Elison, Jason Wolff, et al.

    Introduction: Down syndrome (DS), arising from Trisomy 21, is the most common genetic condition associated with intellectual disability. While smaller total brain volumes have been consistently observed in DS, no longitudinal neuroimaging studies have examined volumetric brain development in DS during infancy, a period of rapid neural growth when interventions may have the greatest impact. Method: High-resolution T1- and T2-weighted images were acquired during natural sleep in a multisite longitudinal cohort of 44 infants with DS and 39 control infants without DS at ages 6 and 12 months. Neuroimaging data were harmonized to reduce batch effects, and a novel deep-learning, repeated-measures segmentation approach was applied to optimize neuroanatomical segmentations. Total intracranial volume (ICV) and bilateral absolute subcortical volumes (amygdala, caudate, hippocampus, pallidum, putamen, thalamus) were first directly compared in infants with and without DS at 6 and 12 months. Hierarchical linear modeling (HLM) evaluated longitudinal group differences for each structure, accounting for sex, gestational age, and laterality. Subcortical group differences estimated by HLM were also compared to group differences in total ICV. Results: ICV in infants with DS was lower than controls at 6 months (12.6%; p< .001) and 12 months (16.3%; p< .001). Subcortical structures displayed a range of lower volumes (6.9%-13.1%; p’s ≤.003) in infants with DS, although the caudate and putamen were exceptions. Caudate volumes were on average lower in DS but not significantly different from controls, while putamen volumes were on average higher in DS but not significantly different from controls, except for the right putamen, which was significantly larger (5.3%; p =.018) at 6 months. In HLM, ICV and all subcortical structures showed slower growth in DS from 6 to 12 months, except for the amygdala and putamen, which displayed similar growth rates to controls. DS-associated reductions in subcortical volumes were similar in magnitude to ICV, although 12-month caudate and 6- and 12-month putamen volumes were enlarged relative to ICV. Conclusion: Infants with DS exhibited substantially reduced ICV and widespread reductions in subcortical volumes and growth from 6-12 months. Across a range of volumetric differences, findings were most distinct in the basal ganglia, for which volume reductions were attenuated in the caudate, while the putamen was uniquely enlarged with comparable growth to controls. These observations support early regional specificity in the neural impact of Trisomy 21 and underscore the utility of infant neuroimaging to inform biologically based interventions and clinical trial readiness in DS.

  • Human cortical organoids recapitulate inter-individual variability in infant brain-growth trajectories

    by Madison R. Glass, Nana Matoba, Alvaro A. Beltran, Niyanta K. Patel, Tala M. Farah, Karthik Eswar, Shivam Bhargava, Karen Huang, Ian Curtin, Sara Ahmed, et al.


  • Open Access

    A Pause, Not a Stop: Language Regression in Toddlers at High Familial Likelihood of Autism

    by Margaret L. McAllister, Tyler McFayden, Shruthi Ravi, Lonnie Zwaigenbaum, Robert Schultz, Annette Estes, Jessica Girault, Mark Shen, Meghan R. Swanson

    Language development, a core pillar of social communication, has variable trajectories in autism that include a regression or loss of skills in roughly 20% of autistic individuals. Language regression is most frequently identified through parent report but can also be observed as a decrease in raw scores on a repeated language assessment (measure-defined). Later language outcomes after regression have been observed to be highly variable, but not lower than children without a language regression. The current study explores rates of parent-reported and measure-defined language regression in a large sample of infants at high familial likelihood of autism due to having an older autistic sibling. Among all participants at high familial likelihood for autism ( n =428), parent-reported regression was observed in 2.8% ( n =12) and was associated with 2.77 times higher odds of receiving an autism diagnosis. Measure-defined regression was observed in 8% ( n =36) and was associated with 1.21 times higher odds of autism diagnosis. These rates of regression are expectedly lower than estimates collected in autistic samples. Neither of these elevated odds was statistically significant and there was low concordance between these groups with only one participant present in both. Nearest-neighbor comparison samples of non-autistic infants at high and low likelihood for autism without language regression were selected to assess differences in language growth trajectories associated with regression. Infants with parent-reported language regression showed comparable language development to a matched high-likelihood sample while infants with measure-defined language regression showed slower overall language development than matched peers. Taken together, our results show that parent-report and direct measurement of regression capture unique aspects of child language development that may not be predictive of an autism diagnosis but may indicate delayed language growth in early toddlerhood. These language outcomes support previous findings of wide heterogeneity among those with regression and continued language growth after loss of skills. Key Points: Language regression can be captured through parent-report or decrease in raw scores on repeated language assessment and is reported in approximately 20% of autistic toddlers. Most research on language regression uses retrospective report of regression in autistic children, but this study prospectively examines regression in toddlers at high familial likelihood for autism who do and do not receive later diagnoses. Parent-reported and measure-defined regression in this high-likelihood sample have low concordance indicating that these may be different events in language development. The presence of language regression was not associated with significantly higher odds of receiving an autism diagnosis. Children who exhibit language regression continue growing and developing language and those with parent-reported regression display comparable language skills to children without language regression at three years of age.


  • Open Access

    Early White Matter Microstructure Alterations in Infants with Down Syndrome

    by Omar Azrak, Dea Garic, Aleeshah Nasir, Meghan R. Swanson, Rebecca L. Grzadzinski, Khalid Al-Ali, Mark D. Shen, Jessica B. Girault, Tanya St. John, Juhi Pandey, et al.


  • Open Access

    Increased Extra‐Axial Cerebrospinal Fluid Volume in Children With Angelman Syndrome: Links to Sleep Problems and Seizures

    by Zumin Chen, Dea Garic, Yinuo Xu, Rachel G. Smith, Leigh Anne H. Weisenfeld, Sun Hyung Kim, Martin A. Styner, Joseph Piven, Benjamin D. Philpot, Heather C. Hazlett, et al.

    Background: Previous studies demonstrated that children with autism have enlarged volumes of extra‐axial cerebrospinal fluid (EA‐CSF) and an increased ratio of EA‐CSF to brain volume, indicating that EA‐CSF is disproportionally increased beyond macrocephaly often observed in autism. It is unknown whether EA‐CSF is disproportionally enlarged in Angelman syndrome (AS), which shares phenotypic features with autism (sleep problems, seizures) but is characterized by microcephaly. This study examined EA‐CSF and total cerebral volume (TCV) in AS children compared with neurotypical (NT) controls to test whether EA‐CSF is disproportionally enlarged and is associated with sleep problems and seizures.Methods: Magnetic resonance imaging scans were acquired in n = 29 AS (M[SD] = 6.95 ± 2.83 years) and n = 27 NT children (M[SD] = 7.96 ± 2.24). EA‐CSF and TCV were compared using analysis of covariance (ANCOVA), controlling for age, sex, and group interactions. In AS, associations between EA‐CSF, sleep quality, and seizure severity were evaluated by linear regression.Results: Children with AS had 22% smaller TCV (p < 0.0001) yet nearly identical EA‐CSF volumes (p = 0.35). The ratio of EA‐CSF to TCV was 48% higher in AS (p < 0.0001). Increased EA‐CSF ratio in AS was associated with sleep initiation problems (p = 0.002) and seizure severity (p = 0.032).Conclusion: Children with AS have disproportionally higher EA‐CSF volume than would be predicted by their smaller brain size. EA‐CSF was associated with sleep problems and seizures, which impact quality of life and are target endpoints of current AS clinical trials. Excessive CSF suggests that CSF circulation might be perturbed in AS, which could have implications for brain waste clearance and impact the biodistribution of AS therapies delivered via CSF.


  • Top Cited Papers

    The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial

    by Jörg F. Hipp, Carlos A. Bacino, Lynne M. Bird, Ina Bruenig-Traebert, Daniel Chan, Marie Claire de Wit, Paulo Fontoura, Gregory Hooper, Ravi Jagasia, Michelle L. Krishnan, et al.

    Angelman syndrome (AS) is a severe genetic neurodevelopmental disorder with no disease-modifying treatments. AS is caused by deletion or mutation of the neuronally imprinted gene encoding the ubiquitin-protein ligase E3A (UBE3A). Rugonersen (RO7248824) is an antisense oligonucleotide that reinstates UBE3A by derepressing the silenced paternal allele. TANGELO was a phase 1, multicenter, open-label, multiple-ascending-dose trial with a long-term extension to investigate the safety and tolerability (primary) and pharmacokinetics (secondary) of rugonersen in children aged 1–12 years with AS (n = 61, F/M: 28/33). Key exploratory endpoints assessing changes following rugonersen treatment were electroencephalogram δ-power (2–4 Hz) and domains of the Bayley Scales of Infant and Toddler Development—Third Edition and Vineland Adaptive Behavior Scales—Third Edition. The primary endpoint was met; rugonersen had an acceptable safety and tolerability profile. Analysis of exploratory endpoints showed that rugonersen led to a dose-dependent partial normalization of the AS-associated electroencephalogram abnormality and revealed signals of clinical improvement in core AS symptom domains beyond expectation from natural history data. The results of the primary study objective support continued development of rugonersen for AS. ClinicalTrials.gov registration: NCT04428281.


  • Open Access

    Identifying and Responding to Gaps in the Academic Research Pipeline: Findings From the International Society for Autism Research (INSAR) Early Career Committee

    by Michele E. Villalobos, Giacomo Vivanti, Subhashini Jayanath, Kimberly Carpenter, Mark D. Shen, Frederick Shic, Jill Locke

    The International Society for Autism Research (INSAR) was established in 2001 with the purpose of providing researchers in the field of autism a specific venue to enhance the quality of multidisciplinary research and elevate the field among the sciences. The autism field and size of the society has now expanded greatly to include over 5000 members, 29% of whom identify as early career researchers. In 2016, a survey was conducted with these early career researchers to identify existing supports and areas of need necessary for a successful and sustained autism research career. Results clearly identified three areas of need: (1) networking opportunities with “change makers,” including funding agencies, journal editors, and senior autism researchers; (2) ensuring early career researchers in the autism research field were diverse and representative of the world; and (3) support from senior researchers to help early career researchers secure their first independent grant and move through promotion. The INSAR Early Career Committee (ECC) was established and developed three initiatives to address the aforementioned gaps: Research Rapid Rounds, the Global Representatives Initiative Pilot (GRIP), and the Mentoring Initiative. The ECC has successfully connected over 34 early career researchers and 40 students/trainees to mentors in 19 unique countries through networking programs and events and has established representatives in seven different countries outside the US and UK. These initiatives are a step towards supporting early career academics in the autism field and bring together autism researchers from around the world to share their work and create professional collaborations to forge our field forward.


  • Open Access

    White matter microstructure in school-age children with down syndrome

    by Dea Garic, Khalid W. Al-Ali, Aleeshah Nasir, Omar Azrak, Rebecca L. Grzadzinski, Robert C. McKinstry, Jason J. Wolff, Chimei M. Lee, Juhi Pandey, Robert T. Schultz, et al.